Cooperation and collaboration between the NHS, government and industry will be key to turbocharging the discovery and delivery of a new wave of medical innovations for patients, says Haseeb Ahmad, managing director UK, Ireland and Nordics at Novartis Pharmaceuticals and Country President, Novartis UK.
Professor Mike Trenell says AI-powered mHealth interventions are allowing pharma and healthcare innovators to support vast numbers of people quickly and cost-efficiently, but we mustn't lose sight of the patient's needs in the race for new tech and services.
ISO IDMP has resumed central focus at EMA, so life sciences firms must step up their own activities if they are to achieve compliance in their marketing submissions by the expected deadline of 2021. AMPLEXOR’s Siniša Belina explores the best approach to maximising returns over the long term.
Adoption of natural language processing and text analytic technologies across healthcare and life science organisations looks set to accelerate with explosive growth in unstructured data and the growing need to gain relevant insight from it.